Comparison Between 2 Protocols for the Treatment of Class II Division 2 Malocclusion
Launched by JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY · Feb 6, 2019
Trial Information
Current as of May 17, 2025
Completed
Keywords
ClinConnect Summary
Fifty four subjects with class II division 2 participated in this study. The subjects were randomly divided into two groups; Group one (28 patients): orthodontic treatment with upper arch bond up first and lower arch was bonded when 4 mm overjet was reached. The treatment continued until 0.019 x 0.025 " stainless steel wires were reached in both arches. Group 2 (26 patients): orthodontic treatment with lower arch bond up first with removable anterior bite plane in upper arch. When 0.019 x 0.025" stainless steel wire was reached, the upper arch was bonded. The treatment continued until 0.019...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 17 years and ≤ 26 years
- • Class II division 2 malocclusion.
- • Overjet (OJ) \< 4 mm.
- • Overbite (OB) covering more than half of the lower incisor height.
- • Mild to moderate crowding with tooth contact displacement no more than 2 mm.
- • Good oral hygiene and healthy periodontium.
- • Exclusion Criteria:-
- • Systemic health problems and medications were taken.
- • History of previous orthodontic treatment.
About Jordan University Of Science And Technology
Jordan University of Science and Technology (JUST) is a leading academic institution dedicated to advancing research and innovation in the fields of science and technology. Committed to fostering a culture of excellence, JUST actively engages in clinical trials aimed at improving health outcomes and contributing to the medical community's knowledge base. With a robust framework for ethical research practices, the university collaborates with local and international partners to explore innovative solutions to pressing health challenges, thereby enhancing patient care and promoting scientific discovery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Irbid, , Jordan
Patients applied
Trial Officials
Susan AlKhateeb, PhD
Principal Investigator
Jordan University of Science and Technology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials